After 17 years at Genentech, Ira Mellman is joining the Parker Institute for Cancer Immunotherapy as president of research.

Scientists develop STITCHR, a retrotransposon-based gene editing tool, by Omar Abudayyeh (Mass General Brigham) and Jonathan ...

RFK Jr.'s first TV interview as HHS head reveals vaccine skepticism, support for measles shots, Novavax concerns, HHS cuts, ...

VC execs write to Sen. Cassidy about FDA staffing concerns, citing delays & uncertainties due to loss of experienced staff & ...

Researchers at AAN meeting discuss myasthenia gravis advances as J&J reports long-term data for nipocalimab, while argenx's ...

With US tariffs on pharmaceuticals likely to come 'very soon,' another of the world's largest drugmakers is announcing plans ...

A biotech incubated by RA Capital has secured a $57.5 million Series B to begin a mid-stage trial for its cardio drug this ...

Trump signals imminent pharma tariffs, with experts including Mollie Sitkowski of Faegre Drinker suggesting 25% levy possible ...

Study shows Dartmouth's Therabot AI chatbot reduced anxiety, depression symptoms in 210-person trial, with users reporting ...

Alzheon's valiltramiprosate (ALZ-801) fails Phase 3 trial in Alzheimer's patients with APOE4 gene copies, showing no significant cognitive decline slowdown despite safer profile than competitors.

Tempest Therapeutics is mulling its business options, including potential exit pathways, after an inability to raise cash to ...

HHS and 19 other government agencies can follow through with firing thousands of probationary workers after a federal appeals ...